Literature DB >> 27885814

Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States.

Shipra Gupta1, Ankit Sakhuja2, Eric McGrath1, Basim Asmar1.   

Abstract

BACKGROUND: We studied the incidence, trend, underlying conditions, microbiology, and outcomes of infective endocarditis (IE) in children during 11 years using Nationwide Inpatient Sample (NIS) database. This is the largest all-payer inpatient care database in the United States containing data for more than 8 million hospital stays from over 1000 hospitals.
METHODS: NIS data from 2000 to 2010 of primary discharge diagnosis of IE in children aged ≤19 years old were studied. Children with underlying congenital heart defects and acquired heart conditions were identified. Microbiological causative agents were recorded. Linear regression was used to assess trend of incidence over time.
RESULTS: An estimated 3,840 (95% CI: 3,395-4,285) children had a discharge diagnosis of IE. The overall incidence was 0.43 per 100 000 children. The incidence was stable over the study period (P = .4 for trend). The majority of patients 56.2% were ≥11 years old and 15.4% were ≤ 1 year. Underlying cardiac conditions were present in 53.5% of patients. Overall 30.2% of cases were culture-negative. Among those with identified pathogens, Staphylococcus species were most common (43.1%) followed by Streptococcus species (39.5%). Viridans Streptococcus group was most common in those with underlying heart disease (32.7%) and S. aureus was most common in those without heart disease (46.9%). Among culture-positive patients, there was a decline in proportion of Staphylococcal IE (P = .03) and an increase in proportion of Streptococcal IE (P = .04). Overall mortality was 2.8%. Patients with Staphylococcal IE had longer median length of stay (12 vs. 9 days; P < .01) and the highest mortality (4.7%).
CONCLUSION: The incidence of IE in children has remained unchanged in the United States during the 11-year study period. Among culture-positive patients there was a significant decrease in Staphylococcal IE and a significant increase of Streptococcal IE. Staphylococcal IE was associated with increased LOS and highest mortality.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  epidemiology; infective endocarditis; microbiology; outcomes; pediatrics

Mesh:

Year:  2016        PMID: 27885814     DOI: 10.1111/chd.12425

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  11 in total

Review 1.  Infective endocarditis in paediatric population.

Authors:  Loay Eleyan; Ameer Ahmed Khan; Gledisa Musollari; Ashwini Suresh Chandiramani; Simran Shaikh; Ahmad Salha; Abdulla Tarmahomed; Amer Harky
Journal:  Eur J Pediatr       Date:  2021-04-14       Impact factor: 3.183

2.  Time-trend population analysis of the clinical and epidemiologic effect on pediatric infective endocarditis after change of antibiotic prophylaxis guidelines.

Authors:  Walter Knirsch; Stefanie Katharina Schuler; Martin Christmann; Roland Weber
Journal:  Infection       Date:  2020-04-30       Impact factor: 3.553

3.  Causes of Death in Infants and Children with Congenital Heart Disease.

Authors:  Jason L Williams; Rachel D Torok; Alfred D'Ottavio; Tracy Spears; Karen Chiswell; Nina E Forestieri; Charlie J Sang; Joseph A Paolillo; Michael J Walsh; Timothy M Hoffman; Alex R Kemper; Jennifer S Li
Journal:  Pediatr Cardiol       Date:  2021-04-22       Impact factor: 1.655

Review 4.  Pediatric Infective Endocarditis: A Literature Review.

Authors:  Lourdes Vicent; Raquel Luna; Manuel Martínez-Sellés
Journal:  J Clin Med       Date:  2022-06-05       Impact factor: 4.964

5.  'Caveat emptor': the cautionary tale of endocarditis and the potential pitfalls of clinical coding data-an electronic health records study.

Authors:  Nicola Fawcett; Bernadette Young; Leon Peto; T Phuong Quan; Richard Gillott; Jianhua Wu; Chris Middlemass; Sheila Weston; Derrick W Crook; Tim E A Peto; Berit Muller-Pebody; Alan P Johnson; A Sarah Walker; Jonathan A T Sandoe
Journal:  BMC Med       Date:  2019-09-04       Impact factor: 8.775

6.  Relationship between death and admission of pediatric patients to intensive care due to Staphylococcus aureus bacteremia acquired in the community, 2014-2017

Authors:  Freddy Israel Pantoja; Willinton Robert Ricaurte; Diana Elizabeth Rosero
Journal:  Biomedica       Date:  2021-03-19       Impact factor: 0.935

7.  Analysis of essential gene dynamics under antibiotic stress in Streptococcus sanguinis.

Authors:  Fadi El-Rami; Xiangzhen Kong; Hardik Parikh; Bin Zhu; Victoria Stone; Todd Kitten; Ping Xu
Journal:  Microbiology       Date:  2018-02       Impact factor: 2.777

8.  Infective Endocarditis After Melody Valve Implantation in the Pulmonary Position: A Systematic Review.

Authors:  Mohammad Abdelghani; Martina Nassif; Nico A Blom; Martijn S Van Mourik; Bart Straver; David R Koolbergen; Jolanda Kluin; Jan G Tijssen; Barbara J M Mulder; Berto J Bouma; Robbert J de Winter
Journal:  J Am Heart Assoc       Date:  2018-06-22       Impact factor: 5.501

9.  (Z)-7,4'-dimethoxy-6-hydroxy-aurone-4-O-β-glucopyranoside attenuates lipoteichoic acid-induced damage in rat cardiomyoblast cells.

Authors:  Qiang Song; Xuegang Xie; Zhi Hu; Jianying Xue; Songlin Zhang; Xinming Xie
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

Review 10.  Clinical Features and Comparison of Kingella and Non-Kingella Endocarditis in Children, Israel.

Authors:  Alexander Lowenthal; Hila Weisblum-Neuman; Einat Birk; Liat Ashkenazi-Hoffnung; Itzhak Levy; Haim Ben-Zvi; Gabriel Amir; Georgy Frenkel; Elchanan Bruckheimer; Havatzelet Yarden-Bilavsky; Dafna Marom; Eran Shostak; Elhanan Nahum; Tamir Dagan; Gabriel Chodick; Oded Scheuerman
Journal:  Emerg Infect Dis       Date:  2021-03       Impact factor: 16.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.